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1. Results of studies of drug self-administration have frequently been suggested as 
indicators of the potential for abuse of theee drugs by humans. Historical data (pre 
1970), although scant, supported this suggestion for drugs such as morphine and ethanol 
that served as reinforcers in both human and non-human experimental subjects. More recent 
information indicated that, while the correlation between human and non-human drug 
self-administistration may be high, there are apparently, occasional exceptions. In the 
narcotic analysis and antidepressant classes of pharmacological compounds, there are drugs 
that maintain high response rates fn animals, but have not yet been shown to result in 
significant abuse problems in man. Various methodological issues, related to the general 
proposition and the exceptions to it are discussed. 
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1. Introduction 
My contribution to this drug self-administration symposium (held at the 6th Annual 
meeting of the Canadian College of Neuropsychopharmacology) is av evaluation of the 
proposition that drugs that are self-administered by experjmental animals are drugs that 
are abused by humans. In other words, the determination that a drug is self-administered 
by experimental animals is predictive of its abuse liability in humans. This is a very 
general, seemingly simple, proposition. It has developed from the increasing body of 
information on drug selfadministration in animals and the rather meagre information, but 
sizable opinion, on human drug abuse. How useful a proposition is it? Does the 
proposition hold both within and across classes of drugs subject to abuse? Are there 
limits to our knowledge, procedures, findings, or concepts that suggest directions for 
future research to test the proposition more thoroughly? 
The validity rf the proposition could hinge on the procedural and conceptual definitions 
of human drug abuse and drug use and as well, on our conceptual skill and experienced 
knowledge in making distinctions in the grey area between abuse and use. However, since 
we need to obviate, if not eliminate, the moralistic overtones inherent in making this 
distinction, we will place our focus on the most objective and direct measures of the 
human drug-taking behavior available. Thus, we will skirt the difficult conceptual issue 
of a general definition of human drug abuse and instead simply describe examples of 
experimental human drug-taking. The more similar these examples are procedurally to 
examples of drug-taking in animals, the easier it will be to use these examples to test 
the proposition. A working definition of drug taking in animals is behavior that is 
reinforced by the delivery of a drug. Usually, the behavior is a simple response. The 
frequency of this response will increase relative to its frequency in a period prior to 
the introduction of drug delivery, if drug delivery is contingent on the response, and 
that particular drug serves as a reinforcer. 
2. Historical sources of the proposjtion 
The rich anecdotal history of human drug taking provided a rough chart for early 
research on drug-taking in animals. The prime concerns appeared, with appropriate 
ethnocentrism, to be narcotic and alcohol selfadministration in animals. Much 
experimental work in animals was devoted to alcohol (see Lester [1966] for an interesting 
review of the early research), but little of it appeared relevant to the human condition 
of alcoholism; animals didn't consume enough ethanol to show significant signs of acute 
intoxication nor did withdrawal signs develop following chronic exposure to ethanol. With 
narcotics, a number of early experiments were done with rodents and a single experiment 
with chimpanzees. However, it was not until a study by Weeks (1962) that a feasible 
technique was demonstrated for studying the reinforcing effect of a narcotic using operant 
conditioning principles. Weeks showed that rats made dependent on morphine by passive 
infusion would readily make a lever-press response that resulted in the intravenous 
delivery of morphine. In addition, ha showed that both behavioral and pharmacological 
manipulations in these rats led to large changes in self-administration behavior. Thus, 
morphine-reinforced responding was increased by reducing the dose of morphine delivered 
(changing reinforcer magnitude), by administration of nalorphine (producing acute 
withdrawal), and changing the number of the responses required for morphine delivery 
(changing response probability and reinforcement interval). Another very important paper 
(Thompson and Schuster, 1964) established similar findings with morphine in rhesus 
monkeys. These studies pointed to the viability of the application of operant 
conditioning techniques and theory to problems of drug dependence, and paved the way for 
later studies that were relevant in testing the proposition we are examining. 
Deneau, Yanagita and Seevers (1969) showed that rhesus monkeys implanted with chronic 
intravenous catheters would self-administer a variety of drugs known to be abused by man. 
They found morphine, codeine, cocaine, d-amphetamine, pentobarbital, and ethanol to 
reinforce a behavioral response in the monkey. A number of other compounds were not 
self-administered at levels greater than those produced by saline. These were nalorphine, 
morphine-nalorphine mixtures, chlorpromazine, caffeine, and mescaline. Deneau and Inoki 
(1967) found intravenous nicotine to maintain modest rates of responding though not 
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clearly above those maintained by the vehicle. Hoffmeioter and Goldberg (1973) found, in 
a situation in which morphine and d-amphetamine were readily self-administered, neither 
chlorpromazine nor imipramine maintained self-injection responding in rhesus monkeys. 
Thus, a variety of drugs that are differentiated therapeutically and on the basis of their 
central mechanisms of actions functioned quite differently as reinforcers in primates. It 
was also of considerable importance that the amounts of compound self-administered led to 
some forms of severe, acute behavioral effects (e.g., stereotypy with amphetamine) or 
chronic effect (e.g., withdrawal signs with alcohol). These effects led some of these 
investigators to argue that only under these conditions would important aspects of human 
drug addiction be captured (Deneau et al., 1969). 
Much of what was known of human self-administration of drugs was established by simple 
narrative or less formal epidemiological studies of drug use and abuse. This information 
suggested that many narcotic analgesics, stimulants, and hypnotic agents were subject to 
abuse in humans, while antipsychotic drugs and antidepressant drugs, in general, were not. 
To my knowledge, the first experimental study of human drug self-administration was 
carried out by Wikler (1952) who followed a single subject self-administering morphine 
over a six-month period. The pattern of drug consumption was quite similar to that of the 
rhesus monkey in the studies described above. Mello and Mendelson (1965) were the first 
investigators to use operant techniques with human alcohol users. They analyzed alcohol 
consumption by alcoholics and found high response rates when beverage alcohol was made 
contingent on the response. These reports were the first to show that humans could serve 
as experimental subjects in studies of drug selfadministration. The study by Hello and 
Mendelson was also important in demonstrating that operant conditioning procedures could 
be applied to human subjects to evaluate the reinforcing effects of drugs. Thus, the 
feasibility of making fairly close comparisons between animal and human experimental 
drug-taking was made excitingly clear. 
The common thread to our proposition, applied to both human and animal experiments, is 
clearly the concept of the drug as a reinforcer. This theme continues as the central 
focus of the next section of the review. This brief and selected view of the history of 
the proposition establishes clearly that many of the prototypic agents that have been 
abused by man are self-administered by primates. Likewise, the negative cases of 
chlorpromazine, nalorphine, and imipramine lent important further evidence to the 
proposition. 
3. Contemporary assessment of the proposition 
Fairly extensive sets of self-administration studies allow interesting generalizations 
about many classes of centrally acting agents. 
3.1. Analgesics. Many morphine-like analgesics are self-jnjected by primates (e.g., Woods 
et al., 1982; Young et al., in press). Virtually all morphine-like drugs that have rapid 
onsets of action function as reinforcers. Indeed, of 16 compounds from each of the major 
chemical families of opioids examined in rhesus monkeys, all maintained self-injection 
responding. There was a strong positive correlation between the potency of a compound in 
maintaining drug-reinforced responding and the potency of the compound in suppressing the 
morphine withdrawal syndrome (Young et al., 1981). When exceptions to this correlation 
were found (e.g., Winger et al., 1983), a slow onset of action was the likely explanation. 
Narcotic analgesics that have actions at different receptors (kappa rather than mu) and 
different profiles of behavorial action are not self-injected at rates comparable to those 
maintained by codeine or morphine even though they have quite rapid onsets of action 
(e.g., Woods et al., 1979, 1982). None of these kappa compounds has been marketed as yet; 
some (e.g., nalorphine and cyclazocine) have produced strong dysphoric effects in humans. 
These agents have also been shown to be aversive in primates (Hoffmeister and 
Wuttke,1973). 
Neither acetylsalicyclic acid, phenylbutasone, phenacetin nor some analogues of these 
agents were self-injected by monkeys (Hoffmeister, 1979). gomiperac also failed to 
maintain significance self-injection responding in the monkey (Woods et al., 1983b). Thus, 
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significant analgesia through non-opiate mechanisms may be obtained with these compounds 
without the production of reinforcing effects. 
It has been found that nalbuphine and butorphanol maintain high rates of responding when 
their intravenous delivery is contingent on an operant response in the monkey (Young et 
al., in press). Yet both of these drugs have been available as analgesics in the United 
States for some time, and no significant abuse of them has been reported. While this may 
indicate that our proposition is flawed, it may also mean that the use of these drug5 is 
restricted to a population unlikely to abuse them. A comparison of the abuse liability of 
these compounds relative to morphine in patients who have received these drug5 for pain 
relief would help to clarify this question. 
3.2. Anti-depressants. The reinforcing effects of these agents has not been studied as 
thoroughly as those of many other classes of agents. Hoffmeister (1977) reported that 
neither intravenous imipramine nor amitryptyline functioned as either positive or negative 
reinforcer5 in the monkey. Nomifensine (Woods, 1978) was reported to maintain significant 
self-injection responding in the monkey, yet there are no reported cases of human abuse, 
though the compound has been marketed in Europe for a considerable period. Bupropion also 
maintains significant self-injection responding in monkey5 (Woods et al., 1983a). Yet, 
preclinical evaluation in humans suggests no characteristics in common with amphetemine as 
least by the oral route of administration (Griffith et al., 1983). These apparent contra- 
dictions to the proposition mean that there may be important species, route of 
administration, and/or procedural differences that need to be examined in greater detail. 
3.3. Major tranquilizers. All major tranquilizers that have been studied to date have 
failed to maintain significant self-injection responding in primates; indeed, some 
maintain responding that prevent5 their injection (e.g. Hoffmeister, 1977). It would be 
extremely interesting both theroretically and from the point of therapeutic trial to 
discover a major tranquilizer that would maintain self-injection responding. 
3.4. Minor tranquilizers. Many of the benxodiasepine minor tranquilizers that have been 
studied to date maintain only modest rates of intravenous drug self-injection in primates 
with the exception of the very short acting compound5 midaxolam and triazolam (Yanagita, 
1981; Woods, 1982; Lukas and Griffiths, 1982). A few formal experiments on drug preference 
suggest that diasepam fails to reinforce responding in normal (Johanson and Uhlenhuth, 
1980) or anxious subjects (deWit et a1.,1983). In sedative abusers, when compared to 
pentobarbital, diazepam is not preferred even at doses at which comparable subjective 
effects are obtained (Griffith8 et al., 1980). Unfortunately, only a very few 
benxodiaxepines have been studied in this way in different human subject populations. 
3.5. Psychomotor stimulants. Many agents of the cocaine-amphetamine type maintain 
self-injection responding (e.g., Wilson et al., 1971; Griffith5 et al., 1976). Slight 
structural modifications, however, lead to significant alterations in reinforcing potency 
and efficacy (Tessel and Woods, 1978) producing some compound5 that apparently suppress 
appetite without having reinforcing effects, e.g., fenfluramine (Woods and Teasel, 1974). 
This difference in reinforcing effect between fenfluramine and amphetamine, however, may 
lead to a negative effect upon compliance when these drugs are used in weight control 
program5 (Bigelow et al., 1980). 
3.6. Other classes of agents. Many of the drugs that share actions with phencyclidine act 
as reinforcer5 (e.5. Balster et al.. 1973: Younn and Woods. 1981): these druns have not 
been studled formally though abuse-of phencyclidine is prevalent in certain countries 
particularly the United States. Certain antihistamines (e.g., tripelennamine [Krohn et 
al., 19821) and local anesthetics (e.g., procaine [Ford and Balster, 19771) act as 
reinforcers though abuse of them by themselves has been noted very infrequently. There is, 
however, abuse of pentasocinetripelennamine combinations in the United States and Canada. 
In summ5ry, some important qualifications need to be considered for the proposition. 
There are drugs that are self-administered by animals for which there is little evidence 
of abuse in humans. These exception5 and their congeners need to be studied more 
thoroughly in different populations of human subjects. Likewise, there are drugs abused 
by human5 that fail to maintain self-injection responding in animals, e.g., 
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tetrahydrocannablnol (Carney et al., 1977) and the hallucinogens, LSD and mescaline 
(Deneau et al., 1969). These compounds, to the extent that it is ethically feasible, 
should also be studied more formally using operant procedures in humans. In addition, 
other behavorial procedures (see below) should be studied in animals. It may be that 
changes in procedure would allow a reinforcing effect of these drugs to be evidenced in 
animals, a finding that would help identify factors that might limit or extend the 
reinforcing effects of these drugs. 
4. Methodological issues 
4.1. Route of Administration. While the reinforcing effects of drugs in animals is 
usually evaluated by the intraveneous route, many drugs are taken by humans by other 
routes of administration than the intravenous route. Route of administration may effect 
the reinforcing effects of some drugs. Considerable progress has been made in animal 
studies using orally delivered drugs as reinforcers (e.g. Meisch and Carroll, 1981) 
allowfng more direct comparison to human drug-taking. Intramuscular injections (Goldberg 
and Gardner, 1981) and intragastric injections (Yanagita, 1981) have also been used 
successfully and may also provide appropriate experimental comparisons across species. 
Finally, inhalation procedures have been used with nitrous oxide (Wood et al., 1977) and 
other agents (Yanagita et al., 1970) providing still other opportunities for comparison in 
human studies and allowing intraspecies comparisons of route of administration on the 
reinforcing effects of drugs. 
4.2. Cohesiveness of experimental approach. It would be ideal to isolate and study each of 
the procedural differences across studies of the reinforcing effects of drugs in animals 
and humans. All concerned would be advised to carry out experiments with the hope in mind 
that some facet of the research could be replicated in other research using other species. 
Often too little regard is given this particular issue. Enormous strides have been made 
over the last 20 years; one can look forward to increasing amounts of procedural 
similarity so that more understanding will be gained of studies both in animals and 
humans. As we gain greater experimental control over drugs as reinforcers one can expect 
to rely less upon the narrative and anecdotal reports of human drug abuse except as a 
guide for supplementing and expanding the information base. 
4.3. Extending and enriching the proposition 
As noted above, the general proposition may be enriched by studing the exceptions to the 
proposition in enough detail to understand why they exist. In addition, much needs to be 
extended especially in the area of human behavioral pharmacology of drug-taking. In 
addition, there are some areas of interest that may have general applicability to the 
study of drugs as reinforcers. 
4.4. Compliance and aversiveness of drugs. The aversive properties of drugs have not been 
nearly as well studied as the nositive reinforcing porperties of drugs, despite the fact 
that the techniques used are nearly identical. Is&s of the aversive porperties of drugs 
in experimental animals and humans are just as relevant to our proposition as are data on 
the rate-maintaining effects of drugs. Demonstration of the aversiveness of drugs in 
animals could predict possible compliance problems in the human population. Likewise 
these types of studies in humans could be carried out in a variety of therapeutic contexts 
in which compliance has been a major problem, e.g., cancer chemotherapy and anti- 
hypertensive medication. 
4.5. Schedules of reinforcement and drugs. The reinforcing effect of s drug is dependent 
upon the schedule of its delivery: the identification of reinforcing effects of some 
drugs (e.g., nicotine [Goldberg and Spealman, 19821) depends critically upon the schedule 
of reinforcement. As we come to know more about the interaction of schedules of 
reinforcement with drugs as reinforcers it may become apparent that some drugs and 
schedules may be more effectively used than others in maintaining or limiting drug self- 
administration in human and animal subjects. Such a generalization may also have 
application to the understanding of human individual differences in the reinforcing 
effects of drugs. 
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4.6. Clarification of discriminative and reinforcing effects of drugs. Many investigators 
sunnest that the discriminative effects of drugs in animals is predictive of the 
subjective effects of drugs in humans, including, "iiking". This may, in turn, be related 
to the reinforcing effect of drugs (e.g., Schuster et al., 1981). There are few studies in 
animals and humans that have drawn such comparisons in the same experimental situation. 
Much will be gained by a careful comparison of these stimulus characteristics in the 
future. 
5. Conclusions 
It should be clear that the proposition, viz., that the drugs that serve as reinforcers 
in animals are abused by humans, is greatly oversimplified. There are some exceptions that 
need further study. Further refinement will give the proposition more general predic- 
tability and usefulness. Nevertheless, the proposition has placed an appropriate focus 
upon the similarity of human and animal drug-taking that takes into account the critical 
nature of the process of reinforcement. 
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